Researchers at the University of Leeds are studying whether medical cannabis could be used as a treatment for glioblastoma. This is the first ever major human trial involving medical cannabis for cancer therapy. The medical cannabis being used is in the form of a spray, and this spray has already been approved to treat multiple sclerosis patients who have muscle spasms.
Professor Susan Short will lead the study, which involves 232 glioblastoma patients from 15 hospitals in the U.K. Two-thirds of them will receive the spray along with a chemotherapy drug. One-third will be given a placebo in place of the spray.
We looked in Foundation to see how medical cannabis is being used in the treatment of brain cancer.
We found three clinical trials:
- A Study of the Safety and Pharmacokinetics of BRCX014 in Patients with Glioblastoma
- A Phase 2 Double-Blind Randomised Controlled Clinical trial assessing the Efficacy of Medicinal Cannabis in patients with recurrent Glioblastoma Multiforme
- AflacSTI901: Peds WPI066
There have also been six patents related to medical cannabis and glioblastoma, most involving dispensing and delivery.
Patents related to medical cannabis and glioblastoma
This chart indicates that there has been a rise in the number of news articles published on the topic from 2020 to 2021.
News articles related to medical cannabis and glioblastoma from 2020 to 2021
Research across all of these databases was conducted quickly and efficiently using ResoluteAI’s Foundation. To talk to a real person about how Foundation can help you, please email us at firstname.lastname@example.org or drop us a line using the link below.